McVie-Veronesi Awards: 3rd Prize - Role of sentinel lymph node biopsy in node positive breast cancer patients? Converting to node negativity after neoadjuvant chemotherapy

Cost-benefit analysis of new cancer medicines: The difficult choices of governments

OncoAlert Round Up for September 15-21, 2023

Osimertinib plus chemotherapy shows superior results versus osimertinib alone for EGFR-mutated advanced lung cancer

A reproducibility study in pulmonary adenocarcinomas supports a revised classification

OncoAlert Round Up for September 1-7, 2023

Reducing stigma for lung cancer and other smoking-related respiratory diseases

Part 6: Which different PARP inhibitors are available

Part 7: Similarities and Differences

Part 8: How PARP inhibitors are being used now

Part 9: What PARP inhibitors mean for the future and what to look out for

The impact of SEABCS 2023